In principle, the COVID-19 outbreak could provide a compelling new justification for expediting the processing of certain Freedom of Information Act requests related to the pandemic. But it is more likely to slow down the handling of most requests as agency employees work remotely and other concerns are understandably prioritized.
The impact of COVID-19 was surveyed by the Congressional Research Service in Freedom of Information Act (FOIA) Processing Changes Due to COVID-19: In Brief, March 27, 2020.
Other noteworthy new and updated reports from CRS include:
U.S. Role in the World: Background and Issues for Congress, updated March 27, 2020
The Employment-Based Immigration Backlog, March 26, 2020
Demographic and Social Characteristics of Persons in Poverty: 2018, March 26, 2020
Occupational Safety and Health Administration (OSHA): Emergency Temporary Standards (ETS) and COVID-19, March 26, 2020
Arms Control and Nonproliferation: A Catalog of Treaties and Agreements, updated March 26, 2020
Congressional Use of Advisory Commissions Following Crises, CRS In Focus, March 25, 2020
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.